ClinicalTrials.Veeva

Menu

Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis (BP Dialysis)

T

The Rogosin Institute

Status

Completed

Conditions

Dialysis Induced Hypertension
End Stage Renal Disease on Dialysis
End Stage Renal Disease
Dialysis Hypotension

Treatments

Device: Intermittent Non-InvasiveBlood Pressure Monitor

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05540457
2022-01

Details and patient eligibility

About

Prospective, single center, open label, non-randomized, post-market study of the Tablo Hemodialysis System and VitalStream Monitor in participants with End-Stage KidneyDisease undergoing In-Center Hemodialysis.

Enrollment

10 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participant is at least 18 years of age and has provided informed consent and has signed a Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant authorization statement.
  • Participant weighs ≥ 34kg.
  • Participant has end stage kidney disease (ESKD) adequately treated by maintenance dialysis.

Exclusion criteria

  • Participant has lack of perfusion of the digitalarteries and arterioles in the lower arm and hand.
  • The Non-Invasive Blood Pressure (NIPB) monitorcuffs (finger and/or brachial) are unable to becorrectly sized to the participant.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

Non-Invasive Blood Pressure (NIPB)Monitors
Experimental group
Description:
NIPB Tablo Brachial Cuff (Intermittent): Will be placed contralateral to the access arm. Blood pressure measurements will be collected pre-dialysis, every 30minutes during dialysis, and post-dialysis. VitalStream Monitor (Continuous):A cuff will be applied to the middlefinger ipsilateral to the accessarm. Blood pressuremeasurements will be collectedpre-dialysis, continuously duringdialysis, and post-dialysis.
Treatment:
Device: Intermittent Non-InvasiveBlood Pressure Monitor

Trial contacts and locations

1

Loading...

Central trial contact

Nelson Chen; Betty-Jane Sloan, MA, CCRC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems